뉴스글로브뉴스와이어
BioCryst to Present New Data for ORLADEYO® (berotralstat) and Navenibart at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting
· 발표
기사 요약
—New data highlight BioCryst's commitment to advancing a portfolio of therapies for people living with HAE—
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…